Julia Mayerle Selected Research

Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)

2/2016	ABO blood type B and fucosyltransferase 2 non-secretor status as genetic risk factors for chronic pancreatitis.
7/2015	Genetic susceptibility factors for alcohol-induced chronic pancreatitis.
4/2015	Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julia Mayerle Research Topics

Disease

55	Pancreatitis 03/2022 - 02/2002
37	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 04/2003
27	Chronic Pancreatitis 03/2022 - 11/2003
27	Neoplasms (Cancer) 11/2021 - 04/2003
19	Adenocarcinoma 01/2022 - 04/2003
9	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2019
9	Fibrosis (Cirrhosis) 01/2022 - 06/2007
9	Inflammation (Inflammations) 11/2021 - 10/2010
8	Infections 01/2022 - 10/2005
7	Pain (Aches) 06/2022 - 10/2005
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 07/2014
6	Necrosis 01/2021 - 12/2004
6	Hereditary pancreatitis 07/2020 - 02/2002
5	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 06/2006
5	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2011
4	Autoimmune Pancreatitis 05/2022 - 06/2007
4	COVID-19 12/2021 - 07/2021
4	Acute Necrotizing Pancreatitis 12/2019 - 12/2003
3	Liver Neoplasms (Liver Cancer) 04/2022 - 10/2019
3	Liver Diseases (Liver Disease) 01/2021 - 07/2014
3	Diabetes Mellitus 01/2020 - 01/2016
3	Disease Progression 01/2020 - 09/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 08/2011
3	Pancreatic Pseudocyst 01/2017 - 03/2008
3	Body Weight (Weight, Body) 01/2016 - 07/2012
2	Ulcerative Colitis 01/2022 - 08/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 05/2014
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2019
2	Gallstones (Gallstone) 01/2021 - 06/2013
2	Hepatic Encephalopathy 08/2020 - 01/2020
2	Sepsis (Septicemia) 02/2020 - 01/2019
2	Margins of Excision 01/2019 - 02/2014
2	Pancreatic Diseases (Pancreatic Disease) 01/2019 - 11/2018
2	Obesity 10/2017 - 01/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 10/2015

Drug/Important Bio-Agent (IBA)

18	CeruletideIBA 01/2021 - 10/2005
17	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 11/2003
14	TrypsinogenIBA 05/2020 - 02/2002
13	TrypsinIBA 01/2021 - 02/2002
10	Biomarkers (Surrogate Marker)IBA 04/2020 - 01/2013
9	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2003
9	Cathepsin BIBA 11/2019 - 06/2002
8	Kazal Pancreatic Trypsin InhibitorIBA 03/2022 - 06/2006
8	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
8	EnzymesIBA 10/2021 - 11/2003
8	Lipase (Acid Lipase)FDA Link 09/2016 - 08/2008
6	Gemcitabine FDA Link 01/2022 - 01/2014
6	Messenger RNA (mRNA)IBA 11/2021 - 04/2003
6	Anti-Bacterial Agents (Antibiotics)IBA 06/2019 - 12/2003
6	Immunoglobulin G (IgG)IBA 01/2018 - 06/2007
5	C-Reactive ProteinIBA 01/2022 - 12/2003
5	LigandsIBA 01/2021 - 05/2007
5	Cadherins (E-Cadherin)IBA 01/2020 - 04/2003
5	CytokinesIBA 01/2020 - 06/2006
4	Sorafenib (BAY 43-9006)FDA Link 04/2022 - 01/2019
4	LipopolysaccharidesIBA 01/2022 - 10/2020
4	IronIBA 01/2022 - 12/2011
4	AntibodiesIBA 12/2021 - 03/2013
4	Pancreatic Elastase (Elastase)IBA 01/2020 - 03/2014
4	Enzyme Precursors (Zymogens)IBA 11/2019 - 11/2003
4	Phosphotransferases (Kinase)IBA 01/2019 - 02/2012
4	CalciumIBA 09/2014 - 02/2002
3	LipidsIBA 12/2021 - 12/2015
3	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 01/2011
3	Amylases FDA Link 05/2020 - 08/2008
3	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2019 - 10/2005
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 10/2005
3	Cathepsin LIBA 01/2018 - 02/2010
3	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 02/2016 - 04/2015
3	Ethanol (Ethyl Alcohol)IBA 07/2015 - 11/2003
2	Peptides (Polypeptides)IBA 05/2022 - 03/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2019
2	Bevacizumab (Avastin)FDA Link 01/2022 - 08/2011
2	Vitamin D FDA LinkGeneric 01/2022 - 12/2019
2	VaccinesIBA 12/2021 - 10/2021
2	AlbuminsIBA 10/2021 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2021 - 10/2019
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2021 - 02/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2020 - 02/2015
2	Cathepsin DIBA 02/2020 - 01/2018
2	InflammasomesIBA 01/2020 - 06/2014
2	Serine Proteases (Serine Protease)IBA 11/2019 - 11/2019
2	Cathepsin GIBA 11/2019 - 11/2019
2	Histones (Histone)IBA 11/2019 - 03/2012
2	ProcalcitoninIBA 06/2019 - 09/2011
2	Sirolimus (Rapamycin)FDA Link 11/2017 - 03/2014
2	Amino Acids FDA Link 11/2017 - 10/2005

Therapy/Procedure

22	Therapeutics 06/2022 - 01/2011
8	Injections 01/2021 - 08/2008
6	Length of Stay 12/2017 - 10/2010
5	Enteral Nutrition (Feeding, Tube) 01/2022 - 12/2003
5	Parenteral Nutrition 01/2022 - 12/2003
4	Ligation 12/2020 - 09/2015
4	Adjuvant Chemotherapy 11/2019 - 02/2014
3	Drug Therapy (Chemotherapy) 01/2021 - 02/2014
3	Precision Medicine 04/2020 - 02/2016
3	Intraperitoneal Injections 01/2020 - 06/2015
3	Conservative Treatment 04/2019 - 12/2003
2	Artificial Respiration (Mechanical Ventilation) 07/2021 - 09/2011
2	Patient Readmission 12/2017 - 05/2015